Skip to content

A COMPARISON BETWEEN THREE CONCENTRATIONS OF DRUG ROPIVACAINE FOR PAIN FREE LABOUR

FINDING THE OPTIMAL CONCENTRATION OF ROPIVACAINE FOR LABOUR PAIN MANAGEMENT USING "PARTURIENT CONTROLLED EPIDURAL ANALGESIA (PCEA): A DOUBLE BLIND, RANDOMIZED TRIAL"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027861
Enrollment
75
Registered
2020-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: GROUP A- 0.0625% ropivacaine with fentanyl 2mcg/ml: After epidural is put and test dose given bolus dose of 8 ml (same combination) given. background infusion of 8ml/hr (same combinatio

Sponsors

Umaid Hospital Dr SNMedical College Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: healthy primi gravida women with a singleton fetus in cephalic presentation at term (>= 37 weeksâ?? gestation), who will request epidural analgesia; an American Society of Anesthesiologists (ASA) physical status class 2; no contraindications for epidural analgesia.

Exclusion criteria

Exclusion criteria: BMI more than 35 kg/m2 ; gestational diabetes; hypertensive disorders; induced labor; premature rupture of membranes ( >18 h duration); fetal growth retardation or a fetus with physical abnormalities. Patients will be excluded from the study if any complications develop that requires cessation of the epidural infusion. This includes patients who have ineffective analgesia, in whom there will be a need to change LA concentration or study design.

Design outcomes

Primary

MeasureTime frame
To find the optimum concentration of ropivacaine from three low dose concentations (0.0625%, 0.1%,0.125%) for effective labour pain management in terms of total dose of L.A. used (mg).Timepoint: Till the end of labour.

Secondary

MeasureTime frame
number of episodes of breakthrough pains, satisfaction with labour analgesia, pain management efficacy, incidence of motor block and maternal and fetal side effects.Timepoint: Till the end of labour.

Countries

India

Contacts

Public ContactDR SHIKHA SONI

DR. S.N.MEDICAL COLLEGE AND ASSOCIATED GROUP OF HOSPITALS, JODHPUR, RAJASTHAN

sarita.janweja@gmail.com9829116420

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026